Cue Biopharma, Inc. (CUE)

CIK 1645460 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cue Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Oct 14, 202640001725092-26-000019
Oct 14, 202640001579629-26-000012
Oct 14, 202640002138368-26-000009
Oct 13, 20261440001579629-26-000010
Oct 13, 20261440001725092-26-000017
Oct 8, 2026SCHEDULE 13G/A0001213900-26-107721
Sep 21, 20268-K0001193125-26-396094
Aug 28, 20264/A0001974756-26-000006
Aug 28, 20264/A0002059447-26-000006
Aug 21, 2026SCHEDULE 13D0001725092-26-000015
Aug 20, 2026EFFECT9999999995-26-002724
Aug 17, 202640002138368-26-000007
Aug 17, 202640001579629-26-000008
Aug 14, 2026SCHEDULE 13G0000938206-26-000041
Aug 14, 202640001725092-26-000013
Aug 14, 202610-Q0001193125-26-352128
Aug 14, 20261440001725092-26-000011
Aug 14, 20268-K0001193125-26-352126
Aug 13, 20261440001579629-26-000006
Aug 12, 2026S-30001193125-26-346867
Aug 3, 20268-K0001193125-26-330730
Aug 3, 202640001320383-26-000006
Aug 3, 202630001320383-26-000004
Jul 30, 20264/A0001725092-26-000009
Jul 22, 2026D0001645460-26-000004